Table 1.
Author | Year | Country | Age | Sample (Case/control) | Specimen | Dysregulated status | Cutoff value | TP | FP | FN | TN | QUADAS-2 |
Abd-El-Fattah et al[19] | 2013 | Egypt | Adult | 29/37 | Serum | Up | Unclear | 28 | 14 | 1 | 23 | 7 |
Cai et al[24] | 2016 | China | Child | 30/30 | Serum | Up | 1.20 | 26 | 3 | 4 | 27 | 5 |
Cao et al[25] | 2014 | China | Child | 40/60 | Serum | Up | 0.71 | 32 | 6 | 8 | 54 | 5 |
Chen et al[26] | 2020 | China | Adult | 68/32 | Sputum | Up | Unclear | 64 | 2 | 4 | 30 | 6 |
Chen et al[27] | 2017 | China | Adult | 100/45 | Serum | Down | 0.36 | 81 | 13 | 19 | 32 | 5 |
Kathirvel et al[16] | 2020 | India | Child | 30/30 | Serum | Up | 0.70 | 28 | 1 | 2 | 29 | 7 |
Ndzi et al[20] | 2019 | Cameroon | Adult | 83/42 | Serum | Up | Unclear | 66 | 21 | 17 | 21 | 6 |
Shi et al[28] | 2019 | China | Adult | 72/45 | Serum | Down | Unclear | 30 | 7 | 42 | 38 | 7 |
Wagh et al[21] | 2017 | India | Adult | 30/30 | Serum | Down | Unclear | 29 | 3 | 1 | 27 | 6 |
Wu et al[22] | 2012 | China | Adult | 21/19 | Serum | Up | Unclear | 10 | 1 | 11 | 18 | 7 |
Zhou et al[23] | 2016 | China | Child | 68/32 | Serum | Up | Unclear | 24 | 3 | 1 | 18 | 7 |
Ying et al[29] | 2020 | China | Adult | 68/122 | Sputum | Up | Unclear | 64 | 15 | 4 | 107 | 7 |
FN = false-negative, FP = false-positive, QUADAS-2 = quality assessment of diagnostic accuracy studies-2, TN = true-negative, TP = true-positive.